Jones Trading Starts AbCellera Biologics (ABCL) at Buy
Tweet
Share
E-mail
Get Alerts ABCL Hot Sheet
Price: $9.12 +31.60%
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 34 | New: 37
Rating Summary:
12 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 34 | New: 37
Join SI Premium – FREE
Jones Trading analyst Debanjana Chatterjee initiates coverage on AbCellera Biologics (NASDAQ: ABCL) with a Buy rating and a price target of $11.00.
For an analyst ratings summary and ratings history on AbCellera Biologics click here. For more ratings news on AbCellera Biologics click here.
Shares of AbCellera Biologics closed at $3.43 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Downgrades Dorman Products (DORM) to Hold
- Reinsurance Group of America (RGA) PT Raised to $274 at Piper Sandler
- Palomar Holdings (PLMR) PT Raised to $167 at Keefe, Bruyette & Woods
Create E-mail Alert Related Categories
New CoverageRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
